A well-known sports injury doctor explains that the Spurs' extensive mileage is likely not to blame for Wembanyama’s newly discovered condition.

Adjusted EBITDA in the fourth quarter of 2024 decreased 5.6% to $174.9 million compared to $185.2 million in the fourth ...